GAFFX
Price
$77.00
Change
+$0.03 (+0.04%)
Updated
May 30 closing price
Net Assets
301.73B
MFEIX
Price
$202.52
Change
+$0.30 (+0.15%)
Updated
May 30 closing price
Net Assets
44.92B
Interact to see
Advertisement

GAFFX vs MFEIX

Header iconGAFFX vs MFEIX Comparison
Open Charts GAFFX vs MFEIXBanner chart's image
American Funds Growth Fund of Amer F3
Price$77.00
Change+$0.03 (+0.04%)
VolumeN/A
Net Assets301.73B
MFS Growth I
Price$202.52
Change+$0.30 (+0.15%)
VolumeN/A
Net Assets44.92B
GAFFX vs MFEIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GAFFX vs. MFEIX commentary
Jun 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GAFFX is a StrongBuy and MFEIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GAFFX has more cash in the bank: 302B vs. MFEIX (44.9B). GAFFX pays higher dividends than MFEIX: GAFFX (0.65) vs MFEIX (0.08). GAFFX was incepted earlier than MFEIX: GAFFX (8 years) vs MFEIX (28 years). MFEIX (0.59) is less costly to investors than GAFFX (0.30). MFEIX is a more actively managed with annual turnover of: 33.00 vs. GAFFX (25.00). MFEIX has a lower initial minimum investment than GAFFX: MFEIX (0) vs GAFFX (1000000). GAFFX annual gain was more profitable for investors over the last year : 9.74 vs. MFEIX (-0.13). MFEIX (49.87) and GAFFX (48.56) have equivalent 5 years return.
GAFFXMFEIXGAFFX / MFEIX
Total Expense Ratio0.300.5852%
Annual Report Gross Expense Ratio0.300.5951%
Fund Existence8 years28 years-
Gain YTD3.3970.417816%
Front LoadN/AN/A-
Min. Initial Investment10000000-
Min. Initial Investment IRAN/AN/A-
Net Assets302B44.9B673%
Annual Yield % from dividends0.650.08853%
Returns for 1 year9.74-0.13-7,395%
Returns for 3 years36.5736.53100%
Returns for 5 years48.5649.8797%
Returns for 10 yearsN/A170.10-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KTTA0.970.03
+3.19%
Pasithea Therapeutics Corp
BIP33.110.45
+1.38%
Brookfield Infrastructure Partners LP
SMWB7.420.01
+0.13%
Similarweb Ltd
ACRS1.46N/A
N/A
Aclaris Therapeutics
CRNX30.51-0.01
-0.03%
Crinetics Pharmaceuticals